FrancophonIA/ELRC3.0 huggingface dataset:
English: What Simponi looks like and contents of the pack Simponi is supplied as solution for injection in a single-use pre-filled pen.
Croatian: Simponi dolazi na tržište u obliku otopine za injekciju u napunjenoj brizgalici za jednokratnu uporabu.
English: Your doctor may decide to prescribe 100 mg (the contents of 1 pre-filled syringe) depending on how well Simponi works for you.
Croatian: Liječnik će Vam možda odlučiti propisati dozu od 100 mg (sadržaj 1 napunjene brizgalice), ovisno o tome koliko dobro Simponi djeluje kod Vas.
English: In the controlled and uncontrolled periods of pivotal trials with a median follow-up of up to 3 years, non-melanoma skin cancer was diagnosed in 5 placebo-treated, 10 golimumab 50 mg-treated and 31
Croatian: U kontroliranim i nekontroliranim razdobljima pivotalnih ispitivanja s medijanom praćenja do 3 godine druge zloćudne bolesti osim melanoma, nemelanomskog raka kože i limfoma dijagnosticirane su u 5 ispitanika koji su primali placebo, 21 ispitanika liječenih golimumabom u dozi od 50 mg te 34 ispitanika liječenih golimumabom u dozi od 100 mg, s incidencijom (95%, CI) na
English: Orange Needle Guard
Croatian: Narančasti štitnik igle
English: • In patients weighing 80 kg or more, 100 mg (the contents of 2 pre-filled syringes) 4 weeks after your last treatment, then every 4 weeks thereafter.
Croatian: • U bolesnika tjelesne težine 80 kg ili veće primjenjuje se doza od 100 mg (sadržaj 2 napunjene brizgalice) 4 tjedna nakon posljednjeg liječenja, a zatim svaka 4 tjedna nakon toga.
English: EU/1/09/546/004 (3 packs, each containing 1 pre-filled syringe)
Croatian: EU/1/09/546/004 (3 pakiranja, svako sadrži 1 napunjenu štrcaljku)
English: You must stop breast-feeding if you are to be given Simponi.
Croatian: Ako ćete započeti liječenje lijekom Simponi, morate prestati dojiti.
English: Simponi 100 mg solution for injection in pre-filled pen.
Croatian: Simponi 100 mg otopina za injekciju u napunjenoj brizgalici.
English: • Please read the enclosed package leaflet
Croatian: • Pročitajte priloženu uputu o lijeku
English: Excipients
Croatian: Imunogenost
English: Table 3 Improvements from baseline in ACR Ped components at week 16 Median percent improvement Simponi 30 mg/m b = 173
Croatian: Tablica 3 Poboljšanje komponenata odgovora ACR Ped od početka ispitivanja do 16. tjedna Medijan postotka poboljšanja
English: * p ≤ 0.001
Croatian: * p ≤ 0,001 NP: nije primjenjivo
English: Dispose of the pre-filled pen after use.
Croatian: Nakon uporabe bacite brizgalicu.
English: Keep the pre-filled pen in the outer carton in order to protect it from light.
Croatian: Napunjenu brizgalicu čuvati u vanjskom pakiranju radi zaštite od svjetlosti.
English: before you begin using Simponi.
Croatian: Ako prestanete primjenjivati Simponi
English: • Do not pull back on the plunger at any time.
Croatian: • Nikada ne tresite štrcaljku.
English: • Abscess
Croatian: • apsces
English: • Flushing
Croatian: • omaglica
English: This is repeated every 21 days for six courses or until the disease gets worse.
Croatian: Ovo se ponavlja svakih 21 dan tijekom šest ciklusa ili do pogoršanja bolesti.
English: Treatment may continue until the disease gets worse.
Croatian: Terapija se može nastaviti do pogoršanja bolesti.
English: It is used after at least one other treatment has failed;
Croatian: Koristi se nakon neuspjeha najmanje jedne linije liječenja;
English: The full EPAR for Hycamtin can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Hycamtin nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Hycamtin topotecan
Croatian: Hycamtin topotekan
English: The main measure of effectiveness was the number of patients whose tumours responded to treatment.
Croatian: Glavna mjera djelotvornosti bio je broj bolesnika koji su odgovorili na liječenje.
English: It was as effective as the standard combination chemotherapy.
Croatian: Bio je podjednako djelotvoran kao standardna kombinacija kemoterapije.
English: This prevents the cancer cells from dividing and they eventually die.
Croatian: Ovo sprječava diobu stanica raka i one naposljetku umiru.
English: Three studies were ‘open', meaning that the medicine was not compared to any other treatment and the patients knew that they were receiving Hycamtin.
Croatian: Tri ispitivanja su bila "otvorena", što znači da se lijek ne može usporediti s bilo kojim drugim liječenjem, te su bolesnici znali da primaju Hycamtin.
English: It is available as a powder to be made up into a solution for infusion (drip) into a vein and as capsules (0.25 and 1 mg).
Croatian: Dostupan je kao prašak za pripravak otopine za infuziju (drip) u venu i kao kapsule (0,25 i 1 mg).
English: It is used when giving the original treatment again is not recommended.
Croatian: Koristi se u bolesnika kod kojih se ne preporučuje ponavljanje izvorne terapije.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Hycamtin on 12 November 1996.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Hycamtin na snazi u Europskoj uniji od 12. studenog 1996.
English: The most common side effects with Hycamtin (seen in more than 1 patient in 10) are neutropenia (low white blood cell counts), febrile neutropenia (neutropenia with fever), thrombocytopenia (low platelet counts), anaemia (low red blood cell counts), leucopenia (low white blood cell counts), nausea (feeling sick), vomiting and diarrhoea (all of which may be severe), constipation, abdominal (tummy) pain, mucositis (mouth sores), alopecia (hair loss), loss of appetite (which may be severe), infections, pyrexia (fever), asthenia (weakness) and fatigue (tiredness).
Croatian: Najčešće nuspojave lijeka Hycamtin (mogu se javiti u više od 1 na 10 osoba) su neutropenja (mali broj bijelih krvnih stanica), febrilna neutropenija (neutropenija praćena vrućicom), trombocitopenija (mali broj trombocita), anemija (mali broj crvenih krvnih stanica), leukopenija (mali broj bijelih krvnih stanica), mučnina (osjećaj slabosti), povraćanje i proljev (oboje ozbiljni), zatvor, abdominalna bol (bol u trbuhu), mukozitis (bolna usna šupljina), alopecija (ispadanje kose), gubitak apetita (koji može biti ozbiljan), infekcije, pireksija (vrućica), astenija (slabost) i iscrpljenost (umor).
English: It is also used together with cisplatin (another cancer medicine) to treat women with cancer of the cervix, when the cancer has come back after radiotherapy, or when the disease is at an advanced stage (has spread beyond the cervix).
Croatian: Koristi se također zajedno sa cisplatinom (drugim protutumorskim lijekom) za liječenje žena s metastatskim karcinomom vrata maternice nakon što se karcinom ponovno pojavio nakon radioterapije, ili ako se bolest nalazi u uznapredovaloj fazi (rak se proširio izvan vrata maternice).
English: The effectiveness was measured by looking at survival or response rates.
Croatian: Djelotvornost je izmjerena promatrajući stopu preživljenja ili odgovora.
English: Other information about Hycamtin
Croatian: Ostale informacije o lijeku Hycamtin
English: This is a summary of the European public assessment report (EPAR) for Hycamtin.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Hycamtin.
English: What measures are being taken to ensure the safe and effective use of Hycamtin?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Hycamtin?
English: In the main study, 21% of the patients who received Hycamtin (23 out of 112) responded to treatment, compared with 14% of the paclitaxel patients (16 out of 114).
Croatian: U glavnom ispitivanju, 21% bolesnika koji su primili Hycamtin (23 od 112) odgovorilo je na terapiju, u usporedbi sa 14% bolesnika na paklitakselu (16 od 114).
English: Hycamtin has also been studied in three main studies in 656 patients with relapsed small cell lung cancer.
Croatian: Hycamtin je također ispitan u tri glavna ispitivanja u 656 bolesnika s recidivom karcinoma pluća malih stanica.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Hycamtin.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet i svoje preporuke za uporabu lijeka Hycamtin.
English: The effectiveness was measured by looking at overall survival.
Croatian: Djelotvornost je izmjerena promatrajući ukupnu stopu preživljenja.
English: In lung cancer, looking at the results obtained in all three studies, the response rate was 20% (480 patients received Hycamtin).
Croatian: U slučaju raka pluća, ako se promatraju rezultati prikupljeni u tri ispitivanja, stopa odgovora je bila 20% (480 bolesnika primilo je Hycamtin).
English: For both ovarian and lung cancer, Hycamtin is given every day for five days with a three-week interval between the start of each course.
Croatian: U slučaju raka jajnika i pluća, Hycamtin se primjenjuje svaki dan tijekom razdoblja od pet dana s intervalom od tri tjedna između početka svakog ciklusa.
English: In ovarian cancer, the studies showed the effectiveness of Hycamtin, with an overall response rate of about 16%.
Croatian: U slučaju raka jajnika, ispitivanja su pokazala djelotvornost lijeka Hycamtin s ukupnom stopom odgovora od otprilike 16%.
English: For lung cancer, Hycamtin can be given as an infusion or, for adults, as capsules.
Croatian: U slučaju raka pluća, Hycamtin se može primjenjivati infuzijom ili, za odrasle, kao kapsule.
English: In cervical cancer, patients receiving the combination of Hycamtin and cisplatin survived an average of 9.4 months, compared with 6.5 months for the patients who received cisplatin only.
Croatian: U slučaju raka vrata maternice, bolesnici koji su zaprimili kombinaciju lijeka Hycamtin i cisplatina preživjeli su prosječno 9,4 mjeseca, u usporedbi sa 6,5 mjeseci u bolesnika koji su primili samo cisplatin.
English: • metastatic cancer of the ovary (when the cancer has spread to other parts of the body).
Croatian: • metastatskim karcinomom jajnika (metastatski znači da se rak proširio na druge dijelove tijela).
English: For more information about treatment with Hycamtin read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Hycamtin pročitajte u uputi o lijeku (također dio EPAR-a), ili se obratite svom liječniku ili ljekarniku.
English: A risk management plan has been developed to ensure that Hycamtin is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Hycamtin.
English: One study compared Hycamtin capsules with symptom control alone and another compared Hycamtin as an infusion with cyclophosphamide, doxorubicin and vincristine (a standard combination of chemotherapy).
Croatian: Jedno je ispitivanje usporedilo kapsule lijeka Hycamtin samo s kontrolom simptoma, a drugo je usporedilo Hycamtin kao infuziju s ciklofosfamidom, doksuribicinom i vinkristinom (standardnom kombinacijom kemoterapije).
English: Why has Hycamtin been approved?
Croatian: Zašto je Hycamtin odobren?
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Hycamtin, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Hycamtin nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Treatment with Hycamtin should only be given under the supervision of a doctor experienced in the use of chemotherapy.
Croatian: Terapija lijekom Hycamtin smije se primjenjivati samo pod nadzorom liječnika s iskustvom u primjeni kemoterapije.
English: What is Hycamtin?
Croatian: Što je Hycamtin?
English: The CHMP decided that Hycamtin's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi lijeka Hycamtin nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: The fourth study involved 226 women, and compared Hycamtin with paclitaxel (another cancer medicine).
Croatian: Četvrto je ispitivanje obuhvatilo 226 žene, i usporedilo je Hycamtin s paklitakselom (drugim protutumorskim lijekom).
English: What is the risk associated with Hycamtin?
Croatian: Koji su rizici povezani s lijekom Hycamtin?
English: Hycamtin given as capsules was as effective as Hycamtin given as an infusion.
Croatian: Hycamtin primjenjivan kao kapsule bio je podjednako djelotvoran kao Hycamtin primjenjivan kao infuzija.
English: Hycamtin also affects non-cancer cells, which causes side effects.
Croatian: Hycamtin djeluje također na netumorske stanice, što uzrokuje nuspojave.
English: Hycamtin must not be used in patients who are breast-feeding, or in patients who have severe bone marrow depression (low white blood cell and platelet counts) before treatment.
Croatian: Hycamtin se ne smije primjenjivati u bolesnica koje doje ili u bolesnica s teškom depresijom koštane srži (mali broj bijelih krvnih stanica i trombocita) prije započinjanja terapije.
English: Hycamtin as an infusion has been studied in 293 women with advanced cervical cancer, where the effectiveness of a combination of Hycamtin and cisplatin was compared with that of cisplatin alone.
Croatian: Hycamtin kao infuzija ispitan je u 293 žena s uznapredovalim rakom vrata maternice, u slučaju kada je djelotvornost kombinacije lijeka Hycamtin i cisplatima uspoređena s djelotvornošću samo cisplatina.
English: When Hycamtin is used on its own for ovarian cancer, it is given by intravenous infusion over 30 minutes.
Croatian: U slučaju kada se Hycamtin primjenjuje kao monoterapija za liječenje karcinoma jajnika, primjenjuje se intravenoznom infuzijom tijekom 30 minuta.
English: Hycamtin is used on its own to treat patients with:
Croatian: Hycamtin se koristi kao monoterapija za liječenje bolesnika s:
English: When the enzyme is blocked, the DNA strands break.
Croatian: U slučaju inhibiranja enzima, lanac DNK puca.
English: The active substance in Hycamtin, topotecan, is a cancer medicine that belongs to the group ‘topoisomerase inhibitors'.
Croatian: Djelatna tvar lijeka Hycamtin, topotekan, je protutumorski lijek koji se ubraja u grupu „inhibitora topoisomeraze".
English: Hycamtin as an infusion has been studied in more than 480 women with ovarian cancer who had failed one treatment with platinum-containing cancer medicines.
Croatian: Hycamtin kao infuzija ispitan je u više od 480 žena s rakom jajnika, u kojih jedna terapija s protutumorskim lijekovima koji sadrže platinu nije bila uspješna.
English: The dose of Hycamtin to be used depends on the type of cancer that it is being used to treat and the patient's weight and height.
Croatian: Doza lijeka Hycamtin, koju treba primijeniti, ovisi o tipu raka koji se liječi te tjelesnoj težini i visini bolesnika.
English: When used with cisplatin in cervical cancer, Hycamtin is given as an infusion on days 1, 2 and 3 (with cisplatin given on day 1).
Croatian: U slučaju primjene sa cisplatinom za liječenje raka vrata maternice, Hycamtin primjenjuje se 1., 2. i 3. dana (pri čemu se cisplatin primjenjuje 1. dan).
English: The third study compared Hycamtin given as an infusion and as capsules.
Croatian: Treće je ispitivanje usporedilo Hycamtin koji se primjenjivao kao infuzija i kao kapsule.
English: Compared with symptom control alone, Hycamtin prolonged survival by
Croatian: U usporedbi sa samo kontrolom simptoma, Hycamtin je produljio preživljenje za 12 tjedana.
English: Doses of Hycamtin may need to be adjusted or treatment delayed, depending on side effects.
Croatian: Ovisno o nuspojavama može biti potrebna prilagodba doza lijeka Hycamtin ili se terapija treba odgoditi.
English: For the full list of all side effects and restrictions with Hycamtin, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja zabilježenih pri primjeni lijeka Hycamtin potražite u uputi o lijeku.
English: Infusions should be carried out in a specialised cancer ward.
Croatian: Infuzije treba primjenjivati samo na odjelima specijaliziranim za primjenu citotoksičnih lijekova.
English: Hycamtin is a cancer medicine that contains the active substance topotecan.
Croatian: Hycamtin je citostatik koji sadrži djelatnu tvar topotekan.
English: What is Hycamtin used for?
Croatian: Za što se Hycamtin koristi?
English: • small cell lung cancer, when the cancer has relapsed (come back).
Croatian: • recidivom (ponovnim pojavljivanjem) karcinoma pluća malih stanica.
English: What benefit has Hycamtin shown during the studies?
Croatian: Koje su koristi lijeka Hycamtin utvrđene u ispitivanjima?
English: How does Hycamtin work?
Croatian: Kako djeluje Hycamtin?
English: How is Hycamtin used?
Croatian: Kako se Hycamtin koristi?
English: It blocks an enzyme called topoisomerase I, which is involved in the division of DNA.
Croatian: I koji je uključen u diobu DNK.
English: For full details, see the summary of product characteristics, also part of the EPAR.
Croatian: Dodatne informacije pročitajte u sažetku opisa svojstava lijeka (također dio EPAR-a).
English: How has Hycamtin been studied?
Croatian: Kako je Hycamtin ispitivan?
English: Date of last renewal: 12/06/2014.
Croatian: Datum posljednje obnove: 12.6.2014.
English: Do not use in pregnant cats.
Croatian: Ne primjenjivati u gravidnih mačaka.
English: Date of first authorisation: 17/06/2009.
Croatian: Datum prvog odobrenja: 17.06.2009.
English: PP MANUFACTURING CORPORATION 175 crossing Boulevard, Suite 200, Framingham, Massachusetts 01702, USA
Croatian: PP MANUFACTURING CORPORATION 175 crossing Boulevard, Suite 200, Framingham, Massachusetts 01702, SAD
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Croatian: Ne koristiti ovaj veterinarsko-medicinski proizvod nakon isteka roka valjanosti naznačenog na etiketi poslije EXP.
English: After the second injection, and subsequent administrations, this reaction is markedly reduced.
Croatian: Nakon druge primjene kao i svih narednih, ova reakcija je znatno umanjena.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Box of 10 or 50 vials
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Kutija s 10 ili 50 bočica
English: A decision to use this vaccine before or after another veterinary medicinal product therefore needs to be made on a case by case basis.
Croatian: Stoga se odluka o primjeni ovog cjepiva prije ili nakon drugog veterinarsko-medicinskog proizvoda treba donositi od slučaja do slučaja.
English: In such cases where maternally derived antibodies are expected, a third injection may be appropriate from 15 weeks of age.
Croatian: U slučajevima gdje se očekuju maternalna protutijela preporučuje se treća primjena od 15. tjedna starosti.
English: EXP {month/year} Once broached use immediately.
Croatian: EXP {mjesec/godina} Jednom otvoren, primijeniti odmah.
English: Therefore, a test for presence of FeLV before vaccination is recommended.
Croatian: Stoga se prije cijepljenja preporučuje provjera prisustva FeLV.
English: Do not mix with any other veterinary medicinal product except FELIGEN RCP or FELIGEN CRP.
Croatian: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom, osim s FELIGEN RCP ili FELIGEN CRP.
English: Active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.
Croatian: Za aktivnu imunizaciju mačaka starijih od 8 tjedana protiv leukemije mačaka, radi prevencije trajne viremije i kliničkih znakova bolesti.
English: No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above.
Croatian: Nisu dostupne nikakve informacije o neškodljivosti i učinkovitosti ovog cjepiva kada se primjenjuje s nekim drugim veterinarsko-medicinskim proizvodom osim prethodno navedenih proizvoda.
English: Maternally derived antibodies can negatively influence the immune response to vaccination.
Croatian: Maternalno stečena protutijela mogu negativno utjecati na imunološki odgovor cijepljenja.
English: 3% aluminium hydroxide gel expressed as mg Al3+
Croatian: 3% aluminij hidroksid gel (izraženo u mg Al3+)
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Croatian: Bilo koji neupotrebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobiveni primjenom tih veterinarsko-medicinskih proizvoda mora se odlagati u s kladu s lokalnim propisima.
English: Plastic or cardboard box of 10 vials.
Croatian: Plastična ili kartonska kutija s 10 bočica.
English: The use is not recommended during lactation.
Croatian: Ne preporučuje se primjena tijekom laktacije.
English: Opalescent liquid.
Croatian: Opalescentna tekućina.
English: Plastic or cardboard box of 50 vials.
Croatian: Plastična ili kartonska kutija s 50 bočica.
English: De-worming at least 10 days prior to vaccination is recommended.
Croatian: Najmanje 10 dana prije cijepljenja preporučuje se dehelmintizacija.
English: The onset of immunity has been demonstrated from 3 weeks after the primary vaccination.
Croatian: Nastanak imuniteta je dokazan 3 tjedna nakon prvog cijepljenja.
English: This local reaction could be a swelling, an oedema or a nodule and resolves spontaneously within from 3 to 4 weeks at the most.
Croatian: Te lokalne reakcije mogu biti oticanje, edem ili kvržica, koje spontano nestaju za 3-4 tjedna.
English: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Croatian: U slučaju nehotičnog samoinjiciranja, odmah potražite pomoć liječnika i pokažite mu uputu o VMP
English: Αθηνών - Λαμίας,
Croatian: 13o χλμ Ε.Ο. Αθηνών - Λαμίας,
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial label
Croatian: OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA MALIM UNUTARNJIM PAKOVANJIMA
English: Sodium chloride Disodium phosphate anhydrous Potassium dihydrogen phosphate Aluminium hydroxide gel Quillaja saponaria Water for injections
Croatian: Dinatrij hidrogen fosfat bezvodni Kalij dihidrogen fosfat Aluminij hidroksid gel Quillaja saponaria.
English: Shake the vial gently before use.
Croatian: Nježno promućkajte bočicu prije primjene.
English: LEUCOGEN suspension for injection for cats
Croatian: LEUCOGEN, suspenzija za injekciju za mačke
English: 06517 Carros France service-conso@virbac.fr
Croatian: VIRBAC France 13e rue LID 06517 Carros France service-conso@virbac.fr
English: Type I glass vials containing one dose (1 ml) of the vaccine closed with a 13 mm-diameter butyl elastomer stopper and aluminium capsule.
Croatian: Staklena bočica (tipa I) koja sadrži jednu dozu (1 mL) cjepiva, sa zatvaračem promjera 13 mm od butil elastomera te aluminijskom kapicom.
English: Administer subcutaneously one dose (1 ml) of the veterinary medicinal product according to the following regimen of vaccination.
Croatian: Aplicirajte subkutano jednu dozu (1 mL) veterinarsko medicinskog proizvoda sukladno sljedećem režimu cijepljenja.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Croatian: Ako primijetite ozbiljne nuspojave ili druge nuspojave koje nisu opisane u uputi o VMP, molimo javite se veterinaru.